Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9614 posts found.

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018 Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …
News
shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018 Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …
News

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten

As the first week of July comes to an end we take a look over the most popular stories of …
News
michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018 Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
News
shutterstock_gonnorrhea

Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer

July 5, 2018 Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma

French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …
News
640px-hiv-budding-color

Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some

July 4, 2018 Research and Development Abivax, HIV, pharma

Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …
News
Medicinal cannabis in a laboratory

Review signals step towards legalisation of medicinal cannabis in UK

July 4, 2018 Research and Development England, cannabis, pharma, review, thc

England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …
News
money-pills-pharma-file

GSK Director indicted in Massachusetts opioid lawsuit

July 4, 2018 Research and Development, Sales and Marketing

The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …
News
pharmafocus_july-august_2018_cover

The July/August issue of Pharmafocus is now live!

July 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma

The new July/August edition of Pharmafocus is now available to read online.
News
800px-lab_mouse_mg_3154

Promising new drug slows Parkinson’s progression in mice

July 4, 2018 Research and Development John Hopkins University, Parkinson's diabetes, pharma

Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …
News
Bayer

Bayer expands Broad Institute partnership to focus on heart failure

July 3, 2018 Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …
News
deborah_standing_cropped_web

Lundbeck appoints new President and CEO

July 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ludbeck, pharma

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …
Appointment
s_world_pills

Global manufacturing harmonisation: Towards a worldwide safety network

July 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing compliance, feature, manufacturing, manufacturing compliance, pharma

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …
Feature
roche__tree

Roche’s Tecentriq combo gives strong Phase 3 showing in triple negative breast cancer

July 2, 2018 Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma

Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …
News
The Gateway to Local Adoption Series

Latest content

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026